XML 30 R19.htm IDEA: XBRL DOCUMENT v3.24.2
Revenue
 6 Months Ended
Jun. 30, 2024
Revenue from Contract with Customer [Abstract]  
Revenue Revenue
Net Sales by Site of Service
MIMEDX has three main sites of service for its products (1) Hospital settings and wound care clinics, which are stable reimbursement settings in which products are used for both wound and surgical applications, (2) Private offices, which generally represents doctors and practitioners with independent operations treating wound patients, and (3) Other, which includes federal facilities, international sales, and other sites of service using products for both wound and surgical applications.
Below is a summary of net sales by site of service (in thousands):
Three Months Ended June 30,Six Months Ended June 30,
2024202320242023
Hospital$47,382 $46,588 $91,139 $88,758 
Private Office26,956 23,750 57,288 45,237 
Other12,869 10,919 23,488 18,938 
Total$87,207 $81,257 $171,915 $152,933 
Net Sales by Product Category
MIMEDX has two product categories: (1) Wound, which reflects products typically used in Advanced Wound Care settings, including the treatment of chronic, non-healing wounds, and (2) Surgical, which reflects products principally used in surgical settings, including the closure of acute wounds or to protect and reinforce tissues and/or regions of interest. The Company manages its product portfolio and pipeline, based upon opportunities in each of these settings.
Below is a summary of net sales by product line (in thousands):
Three Months Ended June 30,Six Months Ended June 30,
2024202320242023
Wound
$57,547 $53,318 $114,595 $98,526 
Surgical
29,660 27,939 57,320 54,407 
Total$87,207 $81,257 $171,915 $152,933 
The Company did not have significant foreign operations or a single external customer from which 10% or more of revenues were derived during the three or six months ended June 30, 2024 or 2023.